Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
-
No effective therapies are available
2018-10-20
No effective therapies are available for motor neuron diseases, including SMARD1. Neural stem cell (NSC) transplantation represents a possible therapeutic strategy for ameliorating the neurological phenotype by multiple mechanisms, including neuroprotection and cell replacement of different CNS ghre
-
These fate analyses relied on
2018-10-20
These fate analyses relied on the restriction of Krox20 expression to BC src inhibitors during early PNS development. However, from embryonic day 15.5 (E15.5), Krox20 also is expressed in Schwann cells (Topilko et al., 1994), thereby preventing later analysis of BC derivatives. To circumvent this p
-
Emerging evidence suggests that paracrine factor profiling o
2018-10-20
Emerging evidence suggests that paracrine factor profiling of MSCs is highly dependent on the microenvironment (Gao et al., 2016). Paracrine factors of iPSC-MSCs are reported to effectively rescue Dox-induced CM damage (Zhang et al., 2015). Nevertheless, how the therapeutic efficacy of MSCs is incre
-
Hello world!
2018-07-29
15229 records 1016/1016 page Previous First page 上5页 1016